← Back to Search

Drug Delivery Device

5mg SAD for Healthy Subjects

Phase 1
Recruiting
Research Sponsored by Biora Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy, adult male or female, 19-50 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 7 days
Awards & highlights

Study Summary

This trial is testing the safety, effectiveness, and how the body processes a new drug called BT-600 in healthy participants. The drug is designed to release a medication called tofacitinib in the

Who is the study for?
This trial is for healthy adults who can participate in a study lasting up to 7 weeks, including screening. Participants will test BT-600, a new drug/device combo designed to deliver medication directly to the colon.Check my eligibility
What is being tested?
The trial tests the safety and effects of BT-600 when given in different doses. It's randomized and double-blind, meaning neither participants nor researchers know who gets the real treatment or placebo.See study design
What are the potential side effects?
Since this is an early-phase trial for a new product, potential side effects are being investigated but may include digestive discomfort or reactions related to swallowing the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a healthy adult between 19 and 50 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Secondary outcome measures
Pharmacokinetic (PK) Assessments

Trial Design

8Treatment groups
Active Control
Placebo Group
Group I: 5mg SADActive Control1 Intervention
Group II: 10mg SADActive Control1 Intervention
Group III: 10mg MADActive Control1 Intervention
Group IV: 5mg MADActive Control1 Intervention
Group V: 5mg SAD placeboPlacebo Group1 Intervention
Group VI: 10mg SAD placeboPlacebo Group1 Intervention
Group VII: 10mg MAD placeboPlacebo Group1 Intervention
Group VIII: 5mg MAD placeboPlacebo Group1 Intervention

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Biora Therapeutics, Inc.Lead Sponsor
Clinical Program LeaderStudy DirectorBiora Therapeutics, Inc.
1 Previous Clinical Trials
47 Total Patients Enrolled
~32 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top